Skip to main content

Young Caroline's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Dec 5, 2024

Accession no.
0001628280-24-050113
Filed
Dec 5, 2024
Trade date
Nov 1-29, 2024
Filing delay
34 daysLate
Rule 10b5-1 plan
Checked

This filing lists 20 non-derivative transactions and 0 derivative transactions. Open-market purchases total $755.45. It was filed 34 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young CarolineCIK 0001684087Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 1, 2024Common StockPPurchaseAcquired+38$1.15+$43.729,055Direct
Nov 4, 2024Common StockPPurchaseAcquired+25$1.17+$29.2529,080Direct
Nov 5, 2024Common StockPPurchaseAcquired+38$1.20+$45.629,118Direct
Nov 6, 2024Common StockPPurchaseAcquired+38$1.20+$45.629,156Direct
Nov 7, 2024Common StockPPurchaseAcquired+38$1.17+$44.4629,194Direct
Nov 8, 2024Common StockPPurchaseAcquired+38$1.18+$44.8429,232Direct
Nov 11, 2024Common StockPPurchaseAcquired+38$1.20+$45.629,270Direct
Nov 12, 2024Common StockPPurchaseAcquired+38$1.20+$45.629,308Direct
Nov 13, 2024Common StockPPurchaseAcquired+38$1.20+$45.629,346Direct
Nov 14, 2024Common StockPPurchaseAcquired+38$1.19+$45.2229,384Direct
Nov 15, 2024Common StockPPurchaseAcquired+38$1.17+$44.4629,422Direct
Nov 18, 2024Common StockPPurchaseAcquired+38$1.18+$44.8429,460Direct
Nov 19, 2024Common StockPPurchaseAcquired+38$1.15+$43.729,498Direct
Nov 20, 2024Common StockPPurchaseAcquired+43$1.13+$48.5929,541Direct
Nov 21, 2024Common StockPPurchaseAcquired+43$1.09+$46.8729,584Direct
Nov 22, 2024Common StockPPurchaseAcquired+16$1.07+$17.1229,600Direct
Nov 25, 2024Common StockPPurchaseAcquired+16$1.09+$17.4429,616Direct
Nov 26, 2024Common StockPPurchaseAcquired+16$1.09+$17.4429,632Direct
Nov 27, 2024Common StockPPurchaseAcquired+16$1.15+$18.429,648Direct
Nov 29, 2024Common StockPPurchaseAcquired+16$1.32+$21.1229,664Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)